Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_assertion description "[ Women with the high activity genotype in exon 3, which could reflect differences in metabolic activation of endogenous or exogenous toxic compounds, may have enhanced susceptibility to pre-eclampsia. However, polymorphisms in the epoxide hydrolase gene do not seem to influence the risk for concurrent development of the HELLP syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_assertion evidence source_evidence_literature NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_assertion SIO_000772 11283205 NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_assertion wasDerivedFrom gad-20130706 NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_assertion wasGeneratedBy ECO_0000203 NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.
- gad-20130706 importedOn "2013-07-06" NP45044.RAxSQ28IsyZyM0uPfuJvpMlw8_NuV6BPGOBrRZa2Lozm0130_provenance.